Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

DGAP-News: COVID-19: CompuGroup Medical provides telemonitoring to relieve hospitals


DGAP-News: CompuGroup Medical SE / Key word(s): Miscellaneous
COVID-19: CompuGroup Medical provides telemonitoring to relieve hospitals

31.03.2020 / 13:20
The issuer is solely responsible for the content of this announcement.


- Relieving hospitals by telemonitoring for COVID-19 cases in the crisis

- The system helps to protect medical and nursing staff

- Hospitalization starts later, ends earlier or is prevented completely

- Patients with corona virus infection can be further monitored in home quarantine after inpatient treatment

- Telemedicine is becoming an important pillar in healthcare in this crisis

Koblenz. COVID-19 patients who remain in home quarantine after inpatient hospital treatment can be treated further and their vital signs are monitored. For other patients, hospitalization may be reduced or may even be prevented completely. This is ensured by a telemonitoring system that CompuGroup Medical SE (CGM) is currently introducing in Italy via its lately acquired company H&S Qualità nel Software SpA. H&S has more than 20 years of experience in this segment and already several Italian hospitals as users. Subsequently it is planned to roll out the system in Germany and other countries. As part of a monitoring system, the H&S Health Platform enables recording vital parameters wirelessly, transmit them to practitioners and alert them immediately in case of an emergency. The software is a certified medical device and has been in use for many years.

"The opportunity of remote monitoring and thus avoiding the hospitalization of patients who are infected but not in a critical state frees up more hospital beds for patients with a particularly severe course of disease," describes Hannes Reichl, Board Member Clinical & Social Care of CompuGroup Medical. "This is the reason why CGM enhanced telemonitoring solutions under the CGM SMART HOME product family."

Patients are using the H&S Health Platform application with an internet-enabled smartphone. A pulse oximeter measures heartbeat and oxygen saturation on a regular basis. If desired, a blood pressure monitor provides additional data. The devices transmit their measurements to the smartphone via Bluetooth and from there to the hospital or doctor's practice. Patients can provide additional data manually via the app. If necessary, the app reminds the patient to take the measurements.

Via a web platform, the practitioner can survey the parameters of his patients in real time as well as set the measurement frequency, the parameters to be monitored and threshold values. If the measured values are outside these thresholds, the system sends an alert immediately to the assigned hospital or general practitioner's practice. Additionally, CGM has established a teleconsultation solution, which allows video communication between doctor and patient. This also helps to protect the health of medical staff and other patients by reducing direct contact with infected patients.

"In this crisis we are experiencing that telemedicine is becoming an important pillar in health care," comments Frank Gotthardt, Chairman of the Management Board and CEO of CompuGroup Medical SE. "Telemonitoring helps to protect healthcare providers, relieves them in their important work and saves urgently needed resources for life-threatened patients in hospitals."

Further information can be obtained at the e-mail address:
[email protected]

About CompuGroup Medical SE
CompuGroup Medical is one of the leading eHealth companies in the world. With a revenue base of MEUR 746 in 2019, its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of more than 1 million users, including doctors, dentists, pharmacists and other health professionals in inpatient and outpatient facilities. With locations in 18 countries and products in 56 countries worldwide, CompuGroup Medical is the eHealth company with one of the highest coverage among eHealth service providers. More than 5'600 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

You can reach our press archive at:

Press releases CGM Group:
https://www.cgm.com/corp/presse/presseinformationen/Presse.en.jsp
 

Contact for media representatives:
Michael Franz
Head of Brand Communication
P +49 (0) 261 8000-6100
F +49 (0) 261 8000-3100
E-mail: [email protected]
Contact for analysts and investors:
Claudia Thomé
Head of Investor Relations
P +49 (0) 261 8000-7030
F +49 (0) 261 8000-3200
E-mail: [email protected]

 



31.03.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: CompuGroup Medical SE
Maria Trost 21
56070 Koblenz
Germany
Phone: +49 (0)261 8000 6200
Fax: +49 (0)261 8000 3200
E-mail: [email protected]
Internet: www.cgm.com
ISIN: DE0005437305
WKN: 543730
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1011615

 
End of News DGAP News Service

1011615  31.03.2020 

fncls.ssp?fn=show_t_gif&application_id=1011615&application_name=news&site_id=sharewise

CompuGroup Medical SE Stock

€68.25
-0.730%
CompuGroup Medical SE shows a slight decrease today, losing -€0.200 (-0.730%) compared to yesterday.
The community is currently still undecided about CompuGroup Medical SE with 1 Buy predictions and 0 Sell predictions.
With a target price of 74 € there is a slightly positive potential of 8.42% for CompuGroup Medical SE compared to the current price of 68.25 €.
Like: 0
Share
EQS Group is a leading international provider of regulatory technology in the fields of corporate compliance and investor relations. In working with EQS Group, thousands of companies worldwide inspire trust by fulfilling complex national and international disclosure obligations, minimizing risks and communicating transparently with stakeholders.




Legal notice

Comments